TWST Twist Bioscience Corp: Accounting Value per Share

Graphic logo of Twist Bioscience (TWST)

Twist Bioscience attracts top-tier bioengineers by offering generous bonuses and RSUs within an ambitious environment at the intersection of IT and genetics. The asset value tracked on this chart currently stands at 7.14. The brand is recognized as the gold standard for DNA synthesis precision, commanding absolute authority among scientists. The use of silicon wafers provides the company with a strategic advantage in production speed and cost over traditional players.

Twist Bio (TWST) Equity per Share: for the period 07/04/2022 - 10/27/2026
Manufactured products of Twist Bioscience Inc

This metric is calculated as the ratio of equity to the number of shares, determining the actual value of the owner's stake. The formula's dynamics react sharply to quarterly reports and changes in reserves. By analyzing the book value per share metric, an investor can discern the fundamental stability of the business. For Twist Bioscience (TWST), this reflects the capitalization of the "Factory of the Future" capacities. The growth of net assets confirms the efficiency of scaling DNA synthesis.

Competitors of Twist Bioscience (TWST)

Net Assets per Single Share TEM (Tempus AI, Inc.)|Qiagen Corp (QGEN) - Net Assets per Share|IONS - Accounting Value per Share|repligen.com (RGEN) - Book Price of a Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|SRPT - Book Value per Share|Accounting Value per Share 10x Genomics TXG|Intellia Therapeutics Inc (NTLA) - Book Price of a Share|STOK (Stoke) - Accounting Value per Share|BioLife (BLFS) - Accounting Value per Share|WVE: Book Value per Share|Net Assets per Share MAZE|SION (Sionna Therapeutics) - Net Assets per Single Share|Net Assets per Share Prime Medicine Inc PRME|Accounting Value per Share Taysha (TSHA)|QURE - Book Price of a Share|Accounting Value per Share MeiraGTx Holdings plc (MGTX)|RGNX - Accounting Value of a Share|Solid Biosciences (SLDB) - Book Value per Share|Ocugen Inc (OCGN) - Net Assets per Single Share|PACB: Book Value per Share|Net Assets per Share BNTC|Design Therapeutics - Net Assets per Single Share|Net Asset Value per Share RCKT (rocketpharma.com)|Net Assets per Single Share FDMT|Net Assets per Share Lexeo Therapeutics Inc. LXEO|KRRO: Book Value per Share|EDIT - Accounting Value per Share|Silence Therapeutics - Book Value per Share|ProQR Therapeutics (PRQR) - Net Assets per Share|Book Value per Share CDXS (Codexis Inc)|Net Asset Value per Share SGMO|Net Assets per Single Share Nautilus Biotechnology NAUT|Equity per Share Metagenomi Therapeutics (MGX)|Precision BioSciences, Inc. - Book Value per Share|Accounting Value per Share Generation Bio Co GBIO|BOLD (Boundless Bio) - Book Value per Share|Exicure, Inc. (XCUR) - Net Asset Value per Share|IMNN - Accounting Value per Share|Book Price of a Share Phio Pharmaceuticals Corp.|Accounting Value per Share MBIO|Accounting Value per Share RNAZ|BNGO (Bionano Genomics, Inc.) - Net Assets per Single Share|Net Assets per Share Applied DNA Sciences Inc APDN|Accounting Value per Share Bluebird Bio (BLUE)|Book Price of a Share ImmunoPrecise Antibodies Ltd IPA|Omega Therapeutics (OMGA) - Book Value per Share|OMIC: Equity per Share|Net Assets per Single Share Regulus Therapeutics Inc.|Syros Pharmaceuticals Inc. (SYRS) - Equity per Share|TBIO (Codex DNA) - Book Value per Share|Book Value per Share TRACON Pharmaceuticals, Inc (TCON)|Accounting Value per Share Unity Biotechnology